Gini Fleming to Flow Cytometry
This is a "connection" page, showing publications Gini Fleming has written about Flow Cytometry.
Connection Strength
0.046
-
A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661. Clin Cancer Res. 2002 Dec; 8(12):3718-27.
Score: 0.046